Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.92 - $1.44 $37,029 - $57,958
-40,249 Reduced 80.67%
9,646 $11,000
Q3 2023

Nov 14, 2023

BUY
$6.56 - $10.95 $40,383 - $67,408
6,156 Added 14.07%
49,895 $341,000
Q2 2023

Aug 14, 2023

BUY
$7.89 - $10.64 $179,031 - $241,432
22,691 Added 107.81%
43,739 $453,000
Q1 2023

May 15, 2023

BUY
$7.07 - $17.95 $6,638 - $16,855
939 Added 4.67%
21,048 $170,000
Q4 2022

Feb 14, 2023

BUY
$14.33 - $18.37 $6,950 - $8,909
485 Added 2.47%
20,109 $316,000
Q3 2022

Nov 14, 2022

BUY
$13.07 - $18.22 $25,290 - $35,255
1,935 Added 10.94%
19,624 $308,000
Q2 2022

Aug 22, 2022

BUY
$10.16 - $17.08 $11,054 - $18,583
1,088 Added 6.55%
17,689 $247,000
Q1 2022

May 16, 2022

BUY
$9.74 - $17.92 $8,532 - $15,697
876 Added 5.57%
16,601 $286,000
Q4 2021

Feb 14, 2022

BUY
$12.27 - $18.49 $1,312 - $1,978
107 Added 0.69%
15,725 $229,000
Q3 2021

Nov 15, 2021

BUY
$13.38 - $18.8 $126,387 - $177,584
9,446 Added 153.05%
15,618 $281,000
Q2 2021

Aug 12, 2021

BUY
$17.08 - $29.6 $105,417 - $182,691
6,172 New
6,172 $109,000
Q2 2020

Aug 14, 2020

SELL
$1.04 - $1.73 $5,739 - $9,547
-5,519 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$2.13 - $7.06 $2,078 - $6,890
-976 Reduced 15.03%
5,519 $12,000
Q4 2018

Feb 15, 2019

BUY
$6.3 - $15.4 $15,976 - $39,054
2,536 Added 64.06%
6,495 $48,000
Q2 2018

Aug 10, 2018

SELL
$16.46 - $20.33 $444 - $548
-27 Reduced 0.68%
3,959 $79,000
Q1 2018

May 17, 2018

SELL
$17.08 - $25.64 $25,705 - $38,588
-1,505 Reduced 27.41%
3,986 $70,000
Q4 2017

Feb 13, 2018

BUY
$21.47 - $27.8 $117,891 - $152,649
5,491
5,491 $136,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.